Gonadotropin.org: Welcome


			Presentations from ASRM October 18, 2004 Optimizing the ART Process Now and in the Future: From Gonadotropins to Enhanced Evaluation of Embryonic Development

	Scott Chappel, PhD
	Recombinant and Urinary Gonadotropins: Comparison of Efficacy, Safety and Consistency View the video introduction to presentation

	Richard P. Marrs, MD
	Human Menopausal Gonadotropin Supplied Luteinizing Hormone Activity - Helpful, Harmful or Necessary? View the video introduction to presentation

	Richard T. Scott, MD, HCLD
	Evaluation of Embryonic Reproductive Competence View the video introduction to presentation

	Presentations from prior meetings
	Improving the efficacy, safety, cost-effectiveness and acceptability of gonadotropin administration prior to in vitro fertilization - presented by William Keye, MD and A Markov Model of the Cost Effectiveness of Human-Derived FSH versus Recombinant FSH Using Comparative Clinical Trial Data - presented by Hind Hatoum, PhD